journal article·2020-02

Crosslinking effects of branched PEG on decellularized lungs of rats for tissue engineering

Mengying Xie, Zhiyi Wang, Xinlong Wan, Jie Weng, Mengyun Tu, Jin Mei, Zhibin Wang, Xiaohong Du, Liangxing Wang, Chan Chen

Publisher page

Abstract

Poly (ethylene glycol) (PEG) has been paid much attention to its applications in tissue engineering. However, the studies on poly (ethylene glycol) in tissue applications were currently far from enough. To investigate the crosslinking effects of poly (ethylene glycol) in mechanical properties, anti-enzymatic ability and cytocompatibility, in this study, the poly (ethylene glycol) was crosslinked to decellularized lung scaffolds from rats. In order to obtain the PEGylated decellularized lung scaffold, the N-succinimidyl S-acetylthioacetate was first used to modify the decellularized lung scaffold, and a four-arm- poly (ethylene glycol) containing four acrylate groups was then crosslinked to the decellularized lung scaffold by the Michael addition reaction between acrylate group and sulfhydryl group. The results showed that the optimal concentration of poly (ethylene glycol) and reaction time of PEGylation of decellularized lung scaffold was 40 mg/mL and 4 h, respectively. Histological examinations, SEM and quantification of tissue morphology by septal thickness consistently indicated no differences between PEGylated and normal decellularized lung scaffold in morphology. Compared with native lung and normal decellularized lung scaffold, the Young's modulus and stiffness of PEGylated decellularized lung scaffold increased significantly, whereas enzymatic degradation rate of PEGylated decellularized lung scaffold decreased significantly, suggesting that poly (ethylene glycol) significantly enhanced the biomechanical property and anti-enzymatic stability of decellularized lung scaffold. Further, no significant differences in cell viability were found between PEGylated and normal decellularized lung scaffold, suggesting no toxicity introduction of poly (ethylene glycol) into decellularized lung scaffold by the crosslinking. These findings may provide useful information for further applications of poly (ethylene glycol) in tissue engineering.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Healthcare Systems and Practices

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China

The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China

School of basic Medical Sciences, Wenzhou Medical University, Wenzhou, China

Funding

Zhejiang Medicines Health Science and Technology Program · WenZhou Science and Technology Bureau · Zhejiang Provincial Natural Science Foundation of China · National Natural Science Foundation of China

References (37)

Show source-provided references
1. 10.1016/j.jcf.2018.02.00610.1016/j.jcf.2018.02.006 ↗
2. 10.1001/jamasurg.2014.203810.1001/jamasurg.2014.2038 ↗
3. Murphy SL · Natl Vital Stat Rep · 2017 · 66 · 1
4. 10.1111/ajt.1456210.1111/ajt.14562 ↗
5. 10.3390/ijms1912411710.3390/ijms19124117 ↗
6. 10.1557/mrc.2017.5810.1557/mrc.2017.58 ↗
7. 10.3389/fbioe.2018.0005610.3389/fbioe.2018.00056 ↗
8. 10.1016/j.mattod.2016.12.00510.1016/j.mattod.2016.12.005 ↗
9. 10.1002/btm2.1011010.1002/btm2.10110 ↗
10. 10.1177/096368971880538310.1177/0963689718805383 ↗
11. 10.1186/s13287-018-0971-510.1186/s13287-018-0971-5 ↗
12. 10.1016/j.biomaterials.2017.06.02710.1016/j.biomaterials.2017.06.027 ↗
13. 10.1089/ten.tea.2015.054610.1089/ten.tea.2015.0546 ↗
14. 10.1016/j.biomaterials.2007.11.00710.1016/j.biomaterials.2007.11.007 ↗
15. 10.1002/jbm.a.3579410.1002/jbm.a.35794 ↗
16. 10.1089/ten.2006.027910.1089/ten.2006.0279 ↗
17. 10.1155/2013/65194510.1155/2013/651945 ↗
18. 10.1016/S0169-409X(01)00240-X10.1016/S0169-409X(01)00240-X ↗
19. 10.3390/ijms1712197410.3390/ijms17121974 ↗
20. 10.1016/j.addr.2015.06.00210.1016/j.addr.2015.06.002 ↗
21. 10.1016/j.cocis.2017.08.00110.1016/j.cocis.2017.08.001 ↗
22. 10.1002/anie.20090267210.1002/anie.200902672 ↗
23. 10.1016/j.biomaterials.2010.01.05810.1016/j.biomaterials.2010.01.058 ↗
24. 10.1186/1475-925X-12-8710.1186/1475-925X-12-87 ↗
25. 10.1007/s00216-002-1347-210.1007/s00216-002-1347-2 ↗
26. 10.1016/j.healun.2018.11.00710.1016/j.healun.2018.11.007 ↗
27. 10.2741/427810.2741/4278 ↗
28. 10.1097/MOT.000000000000058410.1097/MOT.0000000000000584 ↗
29. 10.2217/rme-2018-000810.2217/rme-2018-0008 ↗
30. 10.1016/j.ijbiomac.2015.05.04410.1016/j.ijbiomac.2015.05.044 ↗
31. 10.1016/j.biomaterials.2009.05.08310.1016/j.biomaterials.2009.05.083 ↗
32. 10.1016/j.biomaterials.2010.02.04410.1016/j.biomaterials.2010.02.044 ↗
33. 10.1016/j.biomaterials.2012.06.00510.1016/j.biomaterials.2012.06.005 ↗
34. 10.1016/j.biomaterials.2004.04.02910.1016/j.biomaterials.2004.04.029 ↗
35. 10.1016/j.biomaterials.2014.01.00210.1016/j.biomaterials.2014.01.002 ↗
36. 10.1097/SLA.0b013e318244534110.1097/SLA.0b013e3182445341 ↗
37. 10.1002/jbm.a.3581310.1002/jbm.a.35813 ↗